Indication

Diffuse Intrinsic Pontine Gliomas

1 clinical trial

1 product

Clinical trial

Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005M in Pediatric Subjects With Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma

Status: Active (not recruiting), Estimated PCD: 2023-09-30

Product